On November 27, 2024, Jeffs' Brands announced a binding Letter of Intent (LOI) with Deliverz.AI to form a joint venture (JV) in the U.S. The JV will focus on AI-powered fully autonomous robotic solutions for healthcare logistics. Deliverz.AI's flagship robot, Polly, is already operational at Israel's Sheba Medical Center.The LOI outlines that Deliverz.AI will provide its proprietary robotics technology for a 50% equity stake, while Jeffs' Brands will invest $1 million for the remaining stake. The investment will be phased, with $100,000 upon signing the definitive agreement, another $100,000 upon securing the first U.S. pilot project, and $800,000 in installments by the end of 2025.The JV aims to partner with U.S. medical centers to enhance logistics efficiency. Both companies plan to finalize agreements within 30 days, subject to due diligence and regulatory approvals. The service robotics market is projected to grow significantly, driven by new applications and IoT integration.

On November 27, 2024, Jeffs' Brands announced a binding Letter of Intent (LOI) with Deliverz.AI to form a joint venture (JV) in the U.S. The JV will focus on AI-powered fully autonomous robotic solutions for healthcare logistics. Deliverz.AI's flagship robot, Polly, is already operational at Israel's Sheba Medical Center.The LOI outlines that Deliverz.AI will provide its proprietary robotics technology for a 50% equity stake, while Jeffs' Brands will invest $1 million for the remaining stake. The investment will be phased, with $100,000 upon signing the definitive agreement, another $100,000 upon securing the first U.S. pilot project, and $800,000 in installments by the end of 2025.The JV aims to partner with U.S. medical centers to enhance logistics efficiency. Both companies plan to finalize agreements within 30 days, subject to due diligence and regulatory approvals. The service robotics market is projected to grow significantly, driven by new applications and IoT integration.